Indo US Bio-TechNSE:INDOUS -0.27%63 ROE % is 8.52% as of Mar. 2026, which is 49% below its 10-year median of 16.81. GuruFocus rates NSE:INDOUS with a GF Score™ of 63/100 and a GF Value™ of ₹197.21 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 253 Agriculture companies, Indo US Bio-Tech ranks better than 77.08% on this metric.
The historical rank and industry rank for Indo US Bio-Tech's ROE % or its related term are showing as below:
NSE:INDOUS'
s ROE % Range Over the Past 10 Years
Min: 11.74 Med: 16.81 Max: 34.36
Current: 15.28
During the past 13 years, Indo US Bio-Tech's highest ROE % was 34.36%. The lowest was 11.74%. And the median was 16.81%.
NSE:INDOUS's ROE % is ranked better than 77.08% of 253
companies
in the Agriculture industry
Industry Median: 6.74
vs NSE:INDOUS: 15.28
Indo US Bio-Tech (NSE:INDOUS) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Indo US Bio-Tech ROE % Related Terms
Indo US Bio-Tech ROE % Historical Data
* Premium members only.
The historical data trend for Indo US Bio-Tech's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, Indo US Bio-Tech's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indo US Bio-Tech ROE % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's ROE % distribution charts can be found below:
* The bar in red indicates where Indo US Bio-Tech's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Indo US Bio-Tech (NSE:INDOUS) has a ROE % of 8.52% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Indo US Bio-Tech and its competitors. This is 49% below median its historical median of 16.81. Over the past decade, Indo US Bio-Tech's ROE % has ranged from 11.74 to 34.36. According to the industry distribution chart, Indo US Bio-Tech ranks #58 out of 253 companies in the Agriculture industry, placing it in the top 22.9%.
Is Indo US Bio-Tech's ROE % too high?
Indo US Bio-Tech's current ROE % of 8.52% is 49% below median its 10-year median of 16.81. Over the past 10 years, this metric has ranged from a low of 11.74 to a high of 34.36. The Agriculture industry median ROE % is 6.74. Indo US Bio-Tech's value of 8.52% is 26.4% above this industry median. Based on the distribution chart, Indo US Bio-Tech ranks #58 out of 253 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, Indo US Bio-Tech has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's ROE % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Indo US Bio-Tech ranks #58 out of 253 companies for ROE %. This places Indo US Bio-Tech in the top 23% of its industry — outperforming the majority of peers. The industry median ROE % is 6.74. Indo US Bio-Tech's value of 8.52% is 26.4% above this benchmark. Historically, Indo US Bio-Tech's own ROE % has ranged from 11.74 to 34.36 over the past decade. While the company's 10-year median is 16.81 vs. the industry median of 6.74, Indo US Bio-Tech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Agriculture company?
The median ROE % among Agriculture companies is 6.74, based on 253 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indo US Bio-Tech's current ROE % of 8.52% is 26.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Indo US Bio-Tech and its competitors. For the Agriculture industry, the median ROE % is 6.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo US Bio-Tech's current ROE % is 8.52%, which is 49% below median its own 10-year median of 16.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹197.21, compared to a current price of ₹88.75 — trading 55% below its estimated fair value. The current ROE % is 8.52%, which is 49% below median its 10-year median of 16.81 and 26.4% above the Agriculture industry median of 6.74. Indo US Bio-Tech's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current ROE % is 8.52% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?
Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued.
The current stock price of ₹88.75 is trading 55% below its estimated GF Value™ of ₹197.21.
GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.
Key valuation signals for NSE:INDOUS:
ROE %: 8.52% (49% below median its 10-year median of 16.81)
GF Value™: ₹197.21 vs. price of ₹88.75 (55% below fair value)
Industry Position: 26.4% above the Agriculture median (#58 of 253)
No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
63GF Score
Get the complete analysis for NSE:INDOUS
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOUS has been successfully added to your 
